Trevena
TRVN
#10609
Rank
HK$0.08 M
Marketcap
HK$0.09342
Share price
0.00%
Change (1 day)
-99.26%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -HK$0.25 Billion

According to Trevena's latest financial reports the company's current earnings are HK$0.54 Million. In 2023 the company made an earning of -HK$0.29 Billion, an increase over its 2022 earnings that were of -HK$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.25 Billion-14.26%
2023 -HK$0.29 Billion-30.69%
2022 -HK$0.41 Billion1.38%
2021 -HK$0.41 Billion78.04%
2020 -HK$0.23 Billion21.3%
2019 -HK$0.19 Billion-13.91%
2018 -HK$0.22 Billion-59.75%
2017 -HK$0.54 Billion-31.77%
2016 -HK$0.79 Billion101.73%
2015 -HK$0.4 Billion1.14%
2014 -HK$0.39 Billion114.83%
2013 -HK$0.18 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
HK$64.17 B-26,645.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-HK$5.86 Billion 2,321.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-HK$0.49 Billion 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$179.74 B-74,449.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-HK$4.89 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-HK$80.09 Million-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-HK$0.62 Billion 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA